Androstenedione Market Generated Opportunities, Future Scope 2021-2028 | BIOVET, Indo Phyto Chemicals, Goto Pharmaceutical, Kaizon

Global Androstenedione Market

Androstenedione is a steroid hormone, described as a ‘pro-hormone’, produced mainly in the testes of men and in the ovaries of women. This hormone is known for boosting the production of the testosterone and estrogen hormones in men and women respectively. Androstenedione is generally consumed orally by men, specifically to enhance their testosterone levels, in order to improve their athletic performance, boost recovery from injuries caused during exercise, enhance energy levels, keep the red blood cells healthy, and stimulate sexual desire and performance.

Androstenedione is usually available in the forms of contraceptive pills or capsules, and sometimes, in a spray form, which is administered under the tongue for instant results. The most common side effects of androstenedione in men include low sperm production, painful and prolonged erections, breast development, heart diseases, behavioral changes, and numerous others. In women, the side effects include abnormal menstrual periods and depression. Androstenedione has been found to increase the chances of breast, prostate, or pancreatic cancer, and is said to be poisonous to liver. The control of androstenedione is a complex procedure, due to its secretion from more than one gland, and its rapid conversion to other hormones. The usual dosage of androstenedione is about 50-100 milligrams in the form pills, at least twice a day.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2634

Global Androstenedione Market Dynamics

Surging adoption of androstenedione as a major factor driving the growth of the global androstenedione market. Young people and athletes frequently consume androstenedione to strengthen the body. Moreover, rising prevalence of various infectious inflammation diseases and arthritis are major factors expected to augment growth of the global androstenedione market in the near future. According to the Arthritis Foundation, in 2015, the prevalence rate of osteoarthritis in the U.S. was estimated to be 30.8 million in adults, and around 14 million individuals were found with symptomatic knee arthritis.

However, stringent government regulations imposed on the use of androstenedione is significant factor restraining the growth of the global androstenedione market. For instance, androstenedione is banned by the World Anti-Doping Agency (WADA) and International Olympic Committee (IOC), under the category of androgenic anabolic steroids. However, adverse effects of androstenedione include sustained increase in serum estrogen and increase in serum luteinizing hormone, lean muscle mass, and bone growth problem in children, thus limiting the global androstenedine market development. Furthermore, pregnant women are recommended to not use these pills, as they are linked with higher risks of labor and miscarriage.

Global Androstenedione Market- Regional Outlook

North America, especially the U.S., is expected to hold a dominant position in the global androstenedione market throughout the forecast period. Based on international perspectives on sexual and reproductive health research, in 2015, it was established that fertility control rate decreased by 0.3% in North America, which in turn, augmented the androstenedione market growth in the region. In 2015, an estimated 1.3% adults (3 million) are reported being diagnosed by inflammatory bowel disease.

Global Androstenedione Market- Competitive Analysis

Some of the key players operating in the global androstenedione market include BIOVET, Indo Phyto Chemicals, Goto Pharmaceutical, Kaizon, Jiufu, Darui, Yongning Pharma, Dahua Pharmaceutical, Sito Bio, Dongyao Pharmaceutical, and Huazong Pharmaceuticals.

These players are actively engaged in developing new products to maintain their leading positions in the global market. Androstenedione is primarily marketed to athletes as a potential anabolic agent, and is also claimed to have beneficial effects on general well-being, and quality of life.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/2634

Market Taxonomy

On the basis product type:
• Androstenedione (4-AD)
• Androstadienedione ( ADD)

In terms of application:
• Infectious Inflammation
• Arthritis
• Fertility Control
• Others

By region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/2634

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.